Gene · 6595
Papers3,459
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,459
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tazemetostat: EZH2 Inhibitor. | J Adv Pract Oncol | 2022 | 35369397 | PubTator, text mining | PubMed |
| Aneuploidy tolerance caused by BRG1 loss allows chromosome gains and recovery of fitness. | Nat Commun | 2022 | 35365638 | PubTator, text mining | PubMed |
| DNA methylation signature associated with Bohring-Opitz syndrome: a new tool for functional classification of variants in ASXL genes. | Eur J Hum Genet | 2022 | 35361921 | PubTator, text mining | PubMed |
| SMARCA4-Deficient Undifferentiated Tumor of Lung Mass-A Rare Tumor With the Rarer Occurrence of Brain Metastasis: A Case Report and Review of the Literature. | J Investig Med High Impact Case Rep | 2022 | 35356840 | PubTator, text mining | PubMed |
| Immune Checkpoint Blockade in Chinese Patients With Hepatocellular Carcinoma: Characteristics and Particularity. | Front Oncol | 2022 | 35356200 | PubTator, text mining | PubMed |
| Heterogeneous nuclear ribonucleoprotein K promotes the progression of lung cancer by inhibiting the p53-dependent signaling pathway. | Thorac Cancer | 2022 | 35352475 | PubTator, text mining | PubMed |
| Molecular Virology of SARS-CoV-2 and Related Coronaviruses. | Microbiol Mol Biol Rev | 2022 | 35343760 | PubTator, text mining | PubMed |
| GABPB1-AS1 Promotes the Development of Osteosarcoma by Targeting SP1 and Activating the Wnt/β-Catenin Pathway. | J Oncol | 2022 | 35342417 | PubTator, text mining | PubMed |
| Protein Concentrations in Stored Pooled Platelet Concentrates Treated with Pathogen Inactivation by Amotosalen Plus Ultraviolet a Illumination. | Pathogens | 2022 | 35335674 | PubTator, text mining | PubMed |
| Etiologic Classification of 541 Infantile Spasms Cases: A Cohort Study. | Front Pediatr | 2022 | 35330882 | PubTator, text mining | PubMed |
| Genetic Landscape of Peripheral T-Cell Lymphoma. | Life (Basel) | 2022 | 35330161 | PubTator, text mining | PubMed |
| Relevance of ARID1A Mutations in Endometrial Carcinomas. | Diagnostics (Basel) | 2022 | 35328145 | PubTator, text mining | PubMed |
| The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions. | Biomolecules | 2022 | 35327559 | PubTator, text mining | PubMed |
| Immunotherapy for SMARCB1-Deficient Sarcomas: Current Evidence and Future Developments. | Biomedicines | 2022 | 35327458 | PubTator, text mining | PubMed |
| Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma-What Do We Already Know. | Cancers (Basel) | 2022 | 35326644 | PubTator, text mining | PubMed |
| Dramatic In Vivo Efficacy of the EZH2-Inhibitor Tazemetostat in PBRM1-Mutated Human Chordoma Xenograft. | Cancers (Basel) | 2022 | 35326637 | PubTator, text mining | PubMed |
| Towards a Molecular Classification of Sinonasal Carcinomas: Clinical Implications and Opportunities. | Cancers (Basel) | 2022 | 35326613 | PubTator, text mining | PubMed |
| SWI/SNF Chromatin Remodeling Enzymes in Melanoma. | Epigenomes | 2022 | 35323214 | PubTator, text mining | PubMed |
| A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer. | Mol Cancer | 2022 | 35317841 | PubTator, text mining | PubMed |
| Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: SWI/SNF-deficient Sinonasal Neoplasms: An Overview. | Head Neck Pathol | 2022 | 35307773 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6595/papers?page=41